The FDA conducted inspections at two drug companies in New Jersey during March, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the lowest number conducted by the FDA for this category of companies in New Jersey, accounting for 7.7% of all inspections carried out that month.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 1 | — | — |
| Drug Quality Assurance | 2 | — | — |
| Food and Color Additives Petition Review | — | 1 | — |
| Food Composition, Standards, Labeling and Econ | 8 | — | — |
| Foodborne Biological Hazards | 13 | 8 | — |
| Human Cellular, Tissue, and Gene Therapies | 2 | — | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
